Complex metabolic disharmony in PMM2-CDG paves the way to new therapeutic approaches.
暂无分享,去创建一个
Andreas Hecker | J. Okun | G. Poschet | N. Himmelreich | T. Honzík | S. Strahl | H. Hansíková | C. Thiel | F. Kikul | C. Lüchtenborg | Friederike Bürger | L. Zdražilová | B. Brügger | Gernot Poschet
[1] Yong Geun Jeon,et al. Physiological and pathological roles of lipogenesis , 2023, Nature Metabolism.
[2] J. Marques. The Clinical Management of Pompe Disease: A Pediatric Perspective , 2022, Children.
[3] Thiel Christian,et al. Missense variant c.1460 T > C (p.L487P) enhances protein degradation of ER mannosyltransferase ALG9 in two new ALG9-CDG patients presenting with West syndrome and review of the literature , 2022, Molecular Genetics and Metabolism.
[4] H. Freeze,et al. Chemical Therapies for Congenital Disorders of Glycosylation. , 2021, ACS chemical biology.
[5] Jing Gu,et al. The role of lysosomal membrane proteins in glucose and lipid metabolism , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] Yoshiki Narimatsu,et al. Global view of human protein glycosylation pathways and functions , 2020, Nature Reviews Molecular Cell Biology.
[7] J. Jaeken,et al. Congenital disorders of glycosylation: Still "hot" in 2020. , 2020, Biochimica et biophysica acta. General subjects.
[8] B. Pérez,et al. New and potential strategies for the treatment of PMM2-CDG. , 2020, Biochimica et biophysica acta. General subjects.
[9] H. Blom,et al. Effect of BTD gene variants on in vitro biotinidase activity. , 2019, Molecular genetics and metabolism.
[10] H. Freeze,et al. International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up , 2019, Journal of inherited metabolic disease.
[11] J. Merritt,et al. Fatty acid oxidation disorders. , 2018, Annals of translational medicine.
[12] B. Davidson,et al. Lysosomal storage diseases , 2018, Nature Reviews Disease Primers.
[13] L. de Meirleir,et al. Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial , 2018, Journal of Inherited Metabolic Disease.
[14] C. Ferreira,et al. Recognizable phenotypes in CDG , 2018, Journal of Inherited Metabolic Disease.
[15] R. Eils,et al. Cutis laxa, exocrine pancreatic insufficiency and altered cellular metabolomics as additional symptoms in a new patient with ATP6AP1-CDG. , 2018, Molecular genetics and metabolism.
[16] L. O’Neill,et al. A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation , 2018, Front. Immunol..
[17] G. Matthijs,et al. Congenital disorders of glycosylation (CDG): Quo vadis? , 2017, European journal of medical genetics.
[18] T. D. de Koning. Amino acid synthesis deficiencies , 2017, Journal of inherited metabolic disease.
[19] Hongyu Zhao,et al. Catalase deletion promotes prediabetic phenotype in mice , 2017, Free Radical Biology & Medicine.
[20] Ajit Varki,et al. Biological roles of glycans , 2016, Glycobiology.
[21] J. Smeitink,et al. Treatment options for lactic acidosis and metabolic crisis in children with mitochondrial disease , 2015, Journal of Inherited Metabolic Disease.
[22] Fanny Mochel,et al. The clinical spectrum of inherited diseases involved in the synthesis and remodeling of complex lipids. A tentative overview , 2015, Journal of Inherited Metabolic Disease.
[23] Fanny Mochel,et al. An overview of inborn errors of complex lipid biosynthesis and remodelling , 2015, Journal of Inherited Metabolic Disease.
[24] M. Akram. Citric Acid Cycle and Role of its Intermediates in Metabolism , 2014, Cell Biochemistry and Biophysics.
[25] C. Gieger,et al. Increased amino acids levels and the risk of developing of hypertriglyceridemia in a 7-year follow-up , 2014, Journal of Endocrinological Investigation.
[26] C. Thiel,et al. Screening for congenital disorders of glycosylation in the first weeks of life , 2013, Journal of Inherited Metabolic Disease.
[27] G. Matthijs,et al. Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation‐Ip , 2012, Human mutation.
[28] B. Lentz,et al. Modulation of Prothrombinase Assembly and Activity by Phosphatidylethanolamine* , 2011, The Journal of Biological Chemistry.
[29] C. Thiel,et al. Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. , 2010, Human molecular genetics.
[30] G. Sheldrick,et al. Structure of Tripeptidyl-peptidase I Provides Insight into the Molecular Basis of Late Infantile Neuronal Ceroid Lipofuscinosis* , 2009, Journal of Biological Chemistry.
[31] D. Torre,et al. Reye's and Reye's‐like syndromes , 2008, Cell biochemistry and function.
[32] T. Skotland,et al. Quantification of 13C pyruvate and 13C lactate in dog blood by reversed-phase liquid chromatography-electrospray ionization mass spectrometry after derivatization with 3-nitrophenylhydrazine. , 2007, Journal of pharmaceutical and biomedical analysis.
[33] Ruedi Aebersold,et al. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.
[34] Ronald J A Wanders,et al. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency. , 2002, Biochimica et biophysica acta.
[35] G. Karikas,et al. Low Serum Biotinidase Activity in Children with Valproic Acid Monotherapy , 2001, Epilepsia.
[36] K. von Figura,et al. Abnormal synthesis of mannose 1-phosphate derived carbohydrates in carbohydrate-deficient glycoprotein syndrome type I fibroblasts with phosphomannomutase deficiency. , 1998, Glycobiology.
[37] T. Suormala,et al. BiotinidaseKm-variants: detection and detailed biochemical investigations , 1995, Journal of Inherited Metabolic Disease.
[38] L. Peltonen,et al. Intracellular sorting of aspartylglucosaminidase: the role of N-linked oligosaccharides and evidence of Man-6-P-independent lysosomal targeting. , 1995, DNA and cell biology.
[39] B. Oostra,et al. Human lysosomal alpha-glucosidase: functional characterization of the glycosylation sites. , 1993, The Biochemical journal.
[40] D. Crane,et al. Confirmation that catalase is a glycoprotein. , 1986, Biochemistry International.
[41] M. Hilty,et al. Reye's syndrome and hyperaminoacidemia. , 1974, The Journal of pediatrics.
[42] L. Tong,et al. Striking Diversity in Holoenzyme Architecture and Extensive Conformational Variability in Biotin-Dependent Carboxylases. , 2017, Advances in protein chemistry and structural biology.
[43] B. Brügger,et al. Quantitative analysis of cellular lipids by nano-electrospray ionization mass spectrometry. , 2013, Methods in molecular biology.